Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Peringkat dalam Saham #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Harga Saham
$0.089
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$15.36M
Perubahan (1 hari)
50.59%
Perubahan (1 tahun)
111.85%
Negara
US
Perdagangan Inhibitor Therapeutics, Inc. (INTI)

Kategori

Riwayat pemecahan saham untuk Inhibitor Therapeutics, Inc. (INTI)
Saham Inhibitor Therapeutics, Inc. (simbol: INTI) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 18, 2026.
Satu lembar saham INTI yang dibeli sebelum Aug 18, 2026 sekarang setara dengan 0 lembar saham INTI.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE